Rchr
J-GLOBAL ID:201801005955308875   Update date: Feb. 01, 2024

Yano Yoshitaka

ヤノ ヨシタカ | Yano Yoshitaka
Affiliation and department:
Research field  (1): Clinical pharmacy
Research keywords  (5): Clinical Drug Development ,  biostatistics ,  mathematical model ,  data science ,  pharmacokinetics
Research theme for competitive and other funds  (7):
  • 2022 - 2026 緩和医療における患者報告型アウトカムを活用した薬学的支援方法の確立
  • 2019 - 2022 Best pharmacist support for improving palliative care from early to end of life
  • 2016 - 2020 Analysis of disease specific adverse ivents and its application for medical managements
  • 2016 - 2019 Functional analysis of stem cell derived-Abeta phagocytic cells for the development of cell therapeutic strategies in Alzheimer's disease
  • 2016 - 2019 Establishment of pharmaceutical care for improving QOL in patient receiving palliative care
Show all
Papers (71):
  • Chikako Matsumura, Nanako Koyama, Kaho Okuno, Nobuhiko Nakamura, Morito Sako, Hideo Kurosawa, Takehisa Nomura, Yuki Eguchi, Kazuki Ohba, Yoshitaka Yano. Survival Prediction of Patients Who Were Terminally Ill Using the EORTC QLQ-C15-PAL Scores and Laboratory Test Values. Palliative medicine reports. 2023. 4. 1. 202-207
  • Yugo Chisaki, Hiroki Hata, Chikako Matsumura, Yoshitaka Yano. The Occurrence of Encephalitis Due to Immune Checkpoint Inhibitors: A Pharmacovigilance Study. Therapeutic innovation & regulatory science. 2022. 56. 2. 323-332
  • Hiroki Hata, Chikako Matsumura, Yugo Chisaki, Kae Nishioka, Misaki Tokuda, Kazuyo Miyagi, Tomoki Suizu, Yoshitaka Yano. A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors. Cancer control : journal of the Moffitt Cancer Center. 2022. 29. 10732748221130576-10732748221130576
  • Nanako Koyama, Chikako Matsumura, Yuuna Tahara, Morito Sako, Hideo Kurosawa, Takehisa Nomura, Yuki Eguchi, Kazuki Ohba, Yoshitaka Yano. Symptom clusters and their influence on prognosis using EORTC QLQ-C15-PAL scores in terminally ill patients with cancer. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2022. 30. 1. 135-143
  • Yugo Chisaki, Yoshiki Kuwada, Chikako Matsumura, Yoshitaka Yano. Cost-effectiveness Analysis of Atezolizumab Plus Nab-Paclitaxel for Advanced PD-L1 Positive Triple-Negative Breast Cancer in Japan. Clinical drug investigation. 2021. 41. 4. 381-389
more...
MISC (48):
more...
Books (3):
  • スタンダード薬学シリーズII、医療薬学V.薬物治療に役立つ情報
    2017
  • 薬学数理統計
    2014
  • スタンダード薬学シリーズ、薬と疾病III.薬物治療(2)および薬物治療に役立つ情報(第2版)
Education (3):
  • 1987 - 1990 Kyoto University Graduate School of Pharmaceutical Sciences
  • 1985 - 1987 Kyoto University Graduate School of Pharmaceutical Sciences
  • 1981 - 1985 京都大学薬学部
Professional career (1):
  • 薬学博士 (京都大学)
Work history (5):
  • 2023/04 - 現在 Private Project
  • 2009/04 - 2023/03 Kyoto Pharmaceutical University
  • 2006/05 - 2009/03 Kyoto University
  • 1990/04 - 2006/04 塩野義製薬株式会社 研究所臨床薬理部門、解析センター
  • 1998/04 - 1999/03 University of California San Francisco Pharmaceutical Sciences Post Doctoral Fellow
Association Membership(s) (4):
日本臨床薬理学会 ,  日本計量生物学会 ,  日本薬学会 ,  日本医療薬学会
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page